Gensight Biologics S.A. (ENXTPA:SIGHT) is looking for acquisitions. The company is advancing a number of discussions with potential partners on strategic opportunities, including a merger or acquisition, assessed as one of the relevant options to move forward.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.363 EUR | -0.82% | -6.80% | -21.09% |
07/05 | GenSight Biologics S.A. announced that it expects to receive ?1.546199 million in funding | CI |
05/04 | GenSight: financial visibility assured until the end of April | CF |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.09% | 40.29M | |
+11.91% | 114B | |
+11.60% | 105B | |
-4.68% | 23.83B | |
-0.82% | 21.73B | |
-10.12% | 18.1B | |
-42.12% | 16.34B | |
-17.47% | 16.13B | |
+2.77% | 13.75B | |
+34.58% | 11.76B |
- Stock Market
- Equities
- SIGHT Stock
- News GenSight Biologics S.A.
- Gensight Biologics Seeks Acquisitions